A Study Measuring The Impact Of A Proteomic Assay In Distinguishing Bipolar I Disorder, Bipolar II Disorder, And Major Depressive Disorder In People Who Are Currently Depressed
Posted Date: Feb 24, 2016
- Investigator: Susan Lynn Mcelroy
- Specialties: Psychiatry/Psychology, Bipolar Disorder
- Type of Study: Observational/Survey
The Lindner Center of HOPE is conducting a research study that will evaluate people in a current depressive episode. Participants will be treated under the direction of their doctor and provide 3 blood samples during the study. The purpose of the study is to examine if unipolar depression, bipolar I or bipolar II depression can be determined from a blood sample. The study will last 9 weeks (6 visits during that time). Participants will receive treatment from their regular doctor and not from the study.
Adults 18 To 70 Who Have Been Diagnosed With Major Depression, Bipolar Type I Or Bipolar Type Ii Disorder And Currently Depressed May Be Eligible To Participate.
Mania, Mood Change, Bipolar Disorder, Psychiatry , Manic Depression
For More Information: